PNC Financial Services Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$680K Sell
2,441
-821
-25% -$236K ﹤0.01% 1497
2025
Q4
$988K Buy
3,262
+158
+5% +$49.3K ﹤0.01% 1264
2025
Q3
$870K Buy
3,104
+98
+3% +$26.7K ﹤0.01% 1318
2025
Q2
$725K Sell
3,006
-344
-10% -$81.3K ﹤0.01% 1332
2025
Q1
$816K Sell
3,350
-5,152
-61% -$1.55M ﹤0.01% 1247
2024
Q4
$2.79M Sell
8,502
-253
-3% -$85.9K ﹤0.01% 818
2024
Q3
$2.93M Buy
8,755
+795
+10% +$252K ﹤0.01% 806
2024
Q2
$2.17M Sell
7,960
-1,781
-18% -$518K ﹤0.01% 879
2024
Q1
$3.37M Sell
9,741
-156
-2% -$51.3K ﹤0.01% 752
2023
Q4
$3.2M Sell
9,897
-1,068
-10% -$335K ﹤0.01% 748
2023
Q3
$3.93M Sell
10,965
-69
-0.6% -$26.6K ﹤0.01% 693
2023
Q2
$4.18M Sell
11,034
-191
-2% -$77.7K ﹤0.01% 689
2023
Q1
$5.38M Buy
11,225
+73
+0.7% +$34.2K ﹤0.01% 618
2022
Q4
$4.69M Buy
11,152
+504
+5% +$203K ﹤0.01% 644
2022
Q3
$4.44M Buy
10,648
+71
+0.7% +$35.4K ﹤0.01% 650
2022
Q2
$5.23M Sell
10,577
-94
-0.9% -$49K 0.01% 622
2022
Q1
$6.01M Sell
10,671
-760
-7% -$458K 0.01% 632
2021
Q4
$8.64M Buy
11,431
+4,504
+65% +$3.37M 0.01% 558
2021
Q3
$5.17M Buy
6,927
+140
+2% +$105K ﹤0.01% 643
2021
Q2
$4.37M Sell
6,787
-43
-0.6% -$26.2K ﹤0.01% 691
2021
Q1
$3.9M Buy
6,830
+43
+0.6% +$25.5K ﹤0.01% 693
2020
Q4
$3.96M Sell
6,787
-302
-4% -$172K ﹤0.01% 670
2020
Q3
$3.65M Sell
7,089
-63
-0.9% -$31.9K ﹤0.01% 654
2020
Q2
$3.23M Sell
7,152
-771
-10% -$340K ﹤0.01% 671
2020
Q1
$2.78M Sell
7,923
-227
-3% -$83.5K ﹤0.01% 658
2019
Q4
$3.02M Buy
8,150
+169
+2% +$59.6K ﹤0.01% 709
2019
Q3
$2.66M Buy
7,981
+1
+0% +$326 ﹤0.01% 859
2019
Q2
$2.5M Sell
7,980
-476
-6% -$143K ﹤0.01% 930
2019
Q1
$2.58M Sell
8,456
-2
-0% -$540 ﹤0.01% 946
2018
Q4
$1.96M Buy
8,458
+163
+2% +$43.7K ﹤0.01% 995
2018
Q3
$2.6M Buy
8,295
+63
+0.8% +$19.6K ﹤0.01% 982
2018
Q2
$2.38M Buy
8,232
+480
+6% +$133K ﹤0.01% 979
2018
Q1
$1.94M Buy
7,752
+1,396
+22% +$355K ﹤0.01% 1041
2017
Q4
$1.52M Sell
6,356
-80
-1% -$19.4K ﹤0.01% 1145
2017
Q3
$1.43M Buy
6,436
+704
+12% +$158K ﹤0.01% 1145
2017
Q2
$1.3M Buy
5,732
+161
+3% +$35.1K ﹤0.01% 1162
2017
Q1
$1.11M Sell
5,571
-10
-0.2% -$1.93K ﹤0.01% 1241
2016
Q4
$1.02M Sell
5,581
-110
-2% -$18.8K ﹤0.01% 1274
2016
Q3
$932K Sell
5,691
-12
-0.2% -$1.82K ﹤0.01% 1289
2016
Q2
$815K Buy
5,703
+2
+0% +$285 ﹤0.01% 1328
2016
Q1
$781K Buy
5,701
+125
+2% +$16.4K ﹤0.01% 1365
2015
Q4
$774K Buy
5,576
+145
+3% +$20.1K ﹤0.01% 1318
2015
Q3
$729K Buy
5,431
+41
+0.8% +$5.9K ﹤0.01% 1358
2015
Q2
$811K Buy
5,390
+41
+0.8% +$5.87K ﹤0.01% 1368
2015
Q1
$724K Buy
5,349
+38
+0.7% +$4.71K ﹤0.01% 1397
2014
Q4
$640K Sell
5,311
-12
-0.2% -$1.38K ﹤0.01% 1413
2014
Q3
$604K Sell
5,323
-112
-2% -$13.3K ﹤0.01% 1362
2014
Q2
$651K Buy
5,435
+29
+0.5% +$3.54K ﹤0.01% 1283
2014
Q1
$693K Buy
5,406
+16
+0.3% +$2.05K ﹤0.01% 1219
2013
Q4
$667K Sell
5,390
-2,315
-30% -$282K ﹤0.01% 1213
2013
Q3
$904K Buy
7,705
+2,035
+36% +$240K ﹤0.01% 1044
2013
Q2
$636K Buy
+5,670
New +$665K ﹤0.01% 1173

Other funds holding BIO